Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1042 of 1,261
  1. US 7485663

    Carvedilol

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted
  2. US 7485709

    Identification of a novel BHD gene

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted
  3. US 7485627

    Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation

    The Regents of the University of California · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted
  4. US 7485651

    Compounds with activity on muscarinic receptors

    ACADIA Pharmaceuticals Inc. · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted
  5. US 7485440

    Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted
  6. US 7485457

    Isolated/cloned human NT2 cell lines expressing serotonin and GABA

    The United States of America—Department of Veterans Affairs · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted
  7. US 7485317

    Thermo-reversible polymer for intralumenal implant

    The Regents of the University of California · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted
  8. US 7485296

    PSCA: prostate stem cell antigen and uses thereof in pancreatic cancer

    The Regents of the University of California · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted
  9. US 7485311

    Methods and compositions for preventing and treating male erectile dysfunction

    The Regents of the University of California · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted
  10. US 7485306

    Lutzomyia longipalpis polypeptides and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted
  11. US 7482331

    Diagnosis and treatment of myocardial failure

    The Regents of the University of Colorado · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted
  12. US 7482024

    Compositions comprising an active agent

    Nektar Therapeutics · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted
  13. US 7481995

    Aerosol composition

    University College Cardiff Consultants Limited · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted
  14. US 7482489

    Enantiomerically pure (R)-albuterol dibenzoyltartrate and protected analogs thereof

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted
  15. US 7481212

    Increased dosage metered dose inhaler

    Nektar Therapeutics · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted
  16. US 7482351

    4-pyrimidineamine compounds and their uses as anti-proliferative agents

    Rigel Pharmaceuticals, Inc. · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted
  17. US 7482150

    Virulent systemic feline calicivirus

    The Regents of the University of California · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted
  18. US 7482002

    Method of administering and using VEGF inhibitors for the treatment of prostate cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted
  19. US 7482319

    Vault and vault-like carrier molecules

    The Regents of the University of California · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted
  20. US 7482470

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Jenrin Discovery, LLC · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted
  21. US 7479483

    Tumor-targeted drug delivery systems and uses thereof

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted
  22. US 7479484

    Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity

    Takeda Pharmaceutical Company Limited · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted
  23. US 7479274

    Method of administering and using VEGF inhibitors for the treatment of pancreatic carcinoma

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted
  24. US 7479272

    Method of administering and using VEGF inhibitors for the treatment of breast cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.